ITC Reinstates Import Ban on Biofrontera Devices, Favoring Sun Pharmaceuticals in Patent Dispute
The U.S. International Trade Commission (ITC) has reinstated a ban on the importation of dermatology devices by Biofrontera, following a decisive intervention at the Patent Trial and Appeal Board (PTAB) which favored Sun Pharmaceuticals. This decision underscores the strength of Sun Pharmaceuticals’ patent position in the dermatological treatment sector, where it has held significant influence….